Table 2.
Correlation between TNM stage of pancreatic cancer and ULBP ligands
Ligands | TNM stage I–II (n) | TNM stage III–IV (n) | P-value |
---|---|---|---|
m-ULBP1 | <0.001 | ||
Low | 14 | 41 | |
High | 21 | 4 | |
m-ULBP2 | 0.41 | ||
Low | 26 | 39 | |
High | 9 | 6 | |
m-ULBP3 | 0.09 | ||
Low | 24 | 38 | |
High | 11 | 7 | |
s-ULBP1 (mean ±SD) | 28.78±2.12 | 29.91±1.94 | 0.70 |
s-ULBP2 (mean ±SD) | 137.67±22.84 | 127.83±15.62 | 0.72 |
s-ULBP3 (mean ±SD) | 6.73±0.47 | 7.56±0.29 | 0.07 |
Abbreviations: TNM, tumor, node, metastasis; m-ULBP, membrane ULBP; s-ULBP, soluble ULBP; SD, standard deviation.